Affiliated: Find a Doctor | Symptoms | Diagnosis | Treatment
UCLA’s Bladder Cancer Program offers the most advanced care for bladder cancer. Our doctors are part of The UCLA Institute of Urologic Oncology (the "IUO") and its multidisciplinary team of world-renowned physicians and scientists who are working together to personalize patient care and to develop revolutionary treatments for those diagnosed with bladder cancer.
Comprehensive Care: Bladder cancer patients who choose UCLA for their care have the benefit of our long-held team approach to the treatment and management of bladder cancer that includes world-class urologic oncologists, medical oncologists, radiation oncologists, pathologists, radiologists, nurses and our clinical trial's team working together to personalize patient care. UCLA also has community medical oncology practices so you have easier access to comprehensive cancer care services right in your own neighborhood.
Innovation in Treatment: UCLA offers a variety of innovative treatment options to patients who have been diagnosed with bladder cancer, some of which are not widely available. UCLA has been a pioneer in the innovative, multidisciplinary, translational approach to care, including:
Bladder cancer is marked by the formation of malignant cells in the tissues of the bladder, the organ where urine is stored.
Learn more >
Bladder cancer symptoms may include blood in the urine, frequent urination and pain during urination.
Bladder cancer symptoms, risk factors and prevention >
Both urological and imaging tests are used to diagnose bladder cancer. These tests include a physical exam, urine test, computerized tomography (CT) scan or magnetic resonance imaging (MRI), cystoscopy and a biopsy.
Bladder cancer diagnosis and staging >
The UCLA Bladder Cancer Program offers a variety of innovative treatment options to patients who have been diagnosed with bladder cancer, including standard, minimally invasive and robotic-assisted surgery, as well as clinical trials.
Treatment plans are individualized to each patient’s cancer grade and stage as well as current state of health.
The UCLA Bladder Cancer Program offers patients access to ground-breaking experimental drugs in its Clinical Trials Program that allows patients to receive tomorrow’s approved drugs today.
Clinical Trials >
